Figure 2 | Scientific Reports

Figure 2

From: Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy

Figure 2

GRh2 dose-dependently decreases CSCs-like HepG2 cells.

(A,B) GRh2 dose-dependently decreased the percentage of Aldefluor + cells, by representative flow charts (A) and by quantification (B). (C,D) GRh2 dose-dependently decreased the formation of tumor sphere-like structure, shown as quantification (C) and by representative images (D). (E,F) RT-qPCR for CD133 (E) and EpCAM (F). *p < 0.05. N = 5.

Back to article page